Safety and Tolerability of ShigActive™, a Shigella Spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial
ANTIBIOTICS-BASEL（2024）
Key words
bacteriophage,shigella,bacteriophage therapy,alternative antibacterials,microbiome,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined